iCell® Neurons: Bringing Relevant Neuronal Biology to the Bench
30 Oct 2012

iCell Neurons derived from induced pluripotent stem cells (iPSCs) overcome existing models’ limitations in functionality, purity and reproducibility and offer a virtually unlimited supply of well-characterized cells for drug efficacy screening and safety testing. Importantly, using the iPSC technology to produce neurons enable more biologically relevant disease modeling, improved drug screening strategies, and forward movement toward personalized medicine.

Cellular Dynamics International



Show    per page
1 of 10 Page     1 2 3  ... Next 
Morphometry and Density/Intensity Readings: Avoid Errors in Quantification21 Oct 2014Read
Morphometry and Density/Intensity Readings: Avoid Errors in Quantification20 Oct 2014Read
Validation of the TruSight One Sequencing Panel for Clinical Research16 Oct 2014Read
Ion Mobility Derived Collision Cross Sections to Support Metabolomics and Lipidomics15 Oct 2014Read
Non-targeted and Targeted Analysis of Anionic Metabolites Using Ion Chromatography and High Resolution Accurate Mass Spectrometry1 Oct 2014Read
A new approach to improving early characterization of therapeutic formulations - Viscosizer 2005 Sep 2014Read
An introduction to capillary rheometry - Evaluating material properties under process relevant conditions5 Sep 2014Read
Speed your way though your protein formulation screening by automating your measurements5 Sep 2014Read
Novel analytical technologies for product deformulation - Part 25 Sep 2014Read
Water treatment - Optimize coagulant dosing using zeta potential5 Sep 2014Read